The European Medicines Agency issued a negative "trend" vote for Biotech Inc.'s (Nasdaq: XBIT) marketing authorization application for its candidate antibody for the treatment of colorectal cancer. The stock price plunged $6.79 to close at $10.23.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
San Anselmo | San Anselmo News | San Anselmo Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|